| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/29/2001 | CA2195923C Azetidines |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036642A1 HUMAN MONOCLONAL ANTIBODIES AGAINST TGF-βII RECEPTOR AND MEDICINAL USE THEREOF |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036633A1 Novel protein and dna thereof |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036462A2 Protein c derivatives |
| 05/25/2001 | WO2001036448A2 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036425A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 05/25/2001 | WO2001036422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | WO2001036420A1 Tricyclic azaindolizine derivatives having an spla2- inhibiting effect |
| 05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
| 05/25/2001 | WO2001036398A1 Benzoxa- and benzthiazoles |
| 05/25/2001 | WO2001036395A1 Triazoles as farnesyl transferase inhibitors |
| 05/25/2001 | WO2001036376A1 Novel phenylalanine derivatives |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
| 05/25/2001 | WO2000071114A8 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391651A1 Protein c derivatives |
| 05/25/2001 | CA2391403A1 Novel protein and dna thereof |
| 05/25/2001 | CA2391291A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | CA2391087A1 Imidazole compounds as phosphodiesterase vii inhibitors |
| 05/25/2001 | CA2390292A1 Interferon gamma conjugates |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389862A1 Human monoclonal antibody against tgf-.beta.ii receptor and medicinal use thereof |
| 05/25/2001 | CA2388922A1 23 human secreted proteins |
| 05/23/2001 | EP1101757A1 Heterocyclic compounds as tachykinin receptor antagonists |
| 05/23/2001 | EP1100962A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100961A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100767A1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | EP1100465A1 Medicinal aerosol formulations |
| 05/23/2001 | DE19955476A1 Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Bis-basic compounds as tryptase inhibitors, to processes for their preparation and their use as medicaments |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/23/2001 | CN1295856A Syrup and granules for treating laryngopharyngitis and preparation process thereof |
| 05/23/2001 | CN1295853A Novel medicine for stopping narcotic taking and preparation process thereof |
| 05/23/2001 | CN1295850A Bitongling mixture injection for curing nasal obstruction |
| 05/23/2001 | CN1295846A Earthworm compound capsule |
| 05/23/2001 | CN1066149C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 05/22/2001 | US6235757 Substituted heterocycles |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones |
| 05/22/2001 | US6235739 5-phenyl-3-pyridazinone derivatives and drug composition containing the same |
| 05/22/2001 | US6235732 Neurokinin antagonists |
| 05/22/2001 | US6235725 Methods and compositions for the prevention of tolerance to medications |
| 05/22/2001 | US6235717 Pharmaceutical compounds |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235287 Extract of curcuma amada plant and a compound selected from ocimene, dihydro-ocimene, piene/a-/, curcumene-alpha and beta, linalool, cuminyl alcohol, keto-alchol, turmerone, linalyl acetate, ssfrole, carene-3, myrcene, cineol, limonene |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | US6235266 Dinucleotides useful for the treatment of lung disease |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 05/17/2001 | WO2001034182A2 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase |
| 05/17/2001 | WO2001034180A2 Interferon gamma for the treatment of asthma |
| 05/17/2001 | WO2001034152A1 Nasal drops containing fused pyridazine derivatives |
| 05/17/2001 | WO2001034141A1 Il-8 receptor antagonists |